Evidence map›Paper›PMID 39815617›Full record

ArticleZhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences2025

[Analysis of burden and equality of lower extremity peripheral artery disease in people aged 40 and above in the Belt and Road partner countries from 1990 to 2021].

Guangdian Shen, Longzhu Zhu, Jiayao Ying, Shiyi Shan, Zeyu Luo, Denan Jiang, Jing Wu, Yuefeng Zhu

Abstract readEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Guangdian ShenThe Fourth Affiliated Hospital, Zhejiang University School of Medicine, International Institute of Medicine, International School of Medicine, Zhejiang University, Yiwu 322000, Zhejiang Province, China. gdshen37@zju.edu.cn.
Longzhu ZhuSchool of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, China.
Jiayao YingSchool of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, China.
Shiyi ShanSchool of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, China.
Zeyu LuoSchool of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, China.
Denan JiangThe Fourth Affiliated Hospital, Zhejiang University School of Medicine, International Institute of Medicine, International School of Medicine, Zhejiang University, Yiwu 322000, Zhejiang Province, China.
Jing WuSchool of Public Health, Zhejiang University School of Medicine, Hangzhou 310058, China.
Yuefeng ZhuThe Fourth Affiliated Hospital, Zhejiang University School of Medicine, International Institute of Medicine, International School of Medicine, Zhejiang University, Yiwu 322000, Zhejiang Province, China. srrshzyf@zju.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesTo analyze the disease burden and inequalities of lower extremity peripheral artery disease (LEPAD) among people aged 40 and above in the Belt and Road partner countries from 1990 to 2021.

methodsData were retrieved from the Global Burden of Disease 2021 database. The age-standardized prevalence rates, mortality rates, and the annual rate of years lived with disability (YLDs) of LEPAD were analyzed. Trends were measured using the estimated annual percentage change (EAPC), and the slope index of inequality (SII) and concentration index were used to quantify the absolute and relative inequalities.

resultsIn 2021, the age-standardized prevalence and mortality rates of LEPAD were 3168.26/10

conclusionsLEPAD prevalence and mortality among people aged 40 and above in the Belt and Road partner countries increased, while YLDs rates decreased from 1990 to 2021. Significant differences among people exist depending on gender and country, highlighting the need for enhanced screening, health education, and shared public health strategies across the Belt and Road partner countries.

Indexed as

Lower ExtremityPeripheral Arterial DiseaseAdultAgedCost of IllnessFemaleGlobal Burden of DiseaseHumansMaleMiddle AgedPrevalenceBelt and Road partner countriesFairness analysisGlobal burden of diseaseLower extremity peripheral artery diseaseMiddle-aged and elderly people

Identifiers

PMID39815617
PMCPMC11956856

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.